Arsenal have completed the signing of Eberechi Eze from Crystal Palace after hijacking rivals Tottenham's deal for the talented midfielder, the club announced on Saturday.
The Premier League title hopefuls have confirmed the move after leapfrogging Spurs, who previously appeared unopposed, in the race for Eze.
The England international, 27, has joined for a fee worth up to £67.5 million ($91 million), sources have told ESPN, and becomes Mikel Arteta's seventh signing of the summer window.
- How did Arsenal beat Spurs to Eze, and why do they need him?
- Who needs Eze? Spurs' win at City shows transfers aren't everything
On Wednesday, Tottenham were confident of finalizing a deal after reaching an agreement with Palace -- and personal terms with Eze -- before Arsenal entered the running and quickly moved ahead of their North London rivals.
Eze was willing to join Spurs, but the midfielder is a boyhood Arsenal fan and was previously thought to be open to joining the club when it originally made its interest known.
Spurs are set to move on to other targets, but it ranks as another disappointment in the market for Thomas Frank's side after it missed out on Morgan Gibbs-White, who at one stage was on the brink of joining the club before opting to sign a new contract to stay at Nottingham Forest.
Information from James Olley was used in this report.
Newer articles
Older articles
Gavaskar Calls for Kuldeep Yadav's Inclusion in 2nd Test Amid Bumrah Fitness Concerns, Cites Birmingham Pitch Conditions
Stokes Praises England Openers' Key Role in Record-Breaking Chase Against India
Black Caps Set for Blockbuster Home Summer Against Cricket Heavyweights: Australia, England, West Indies, and South Africa to Tour New Zealand
5 Warning Signs of Prediabetes You Might Be Missing
Former Selector Blasts India's Fielding Lapses After Test Defeat to England; 'Simple Catches Cost Us'
Nitish Rana Set for Delhi Comeback After Disappointing Uttar Pradesh Spell
Ederson Exits Man City for Fenerbahce, Paving the Way for Donnarumma's Etihad Arrival
Gambhir Stands by India's Lower Order Despite Test Collapse; Cites Missed Catches as Key Factor
India's First Dengue Vaccine: Phase 3 Trials Approach Finish Line, Promising Hope Against Deadly Virus
Rishabh Pant's Unorthodox Batting Revolutionizing Cricket, Claims Greg Chappell